2Seventy Bio Ownership

TSVT Stock  USD 3.65  0.13  3.44%   
2Seventy Bio holds a total of 51.59 Million outstanding shares. The majority of 2Seventy Bio outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in 2Seventy Bio to benefit from reduced commissions. Therefore, institutional investors are subject to a different set of regulations than regular investors in 2Seventy Bio. Please pay attention to any change in the institutional holdings of 2Seventy Bio as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as 2Seventy Bio in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of 2Seventy Bio, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Dividend Paid And Capex Coverage Ratio is likely to drop to -12.64 in 2024. Common Stock Shares Outstanding is likely to drop to about 32.7 M in 2024. Net Loss is likely to drop to about (240.2 M) in 2024.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in 2Seventy Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.

2Seventy Stock Ownership Analysis

About 91.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.85. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. 2Seventy Bio recorded a loss per share of 1.83. The entity had not issued any dividends in recent years. 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts. 2Seventy Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 437 people. To find out more about 2Seventy Bio contact the company at 617 675 7270 or learn more at https://www.2seventybio.com.
Besides selling stocks to institutional investors, 2Seventy Bio also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different 2Seventy Bio's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align 2Seventy Bio's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

2Seventy Bio Quarterly Liabilities And Stockholders Equity

503.85 Million

2Seventy Bio Insider Trades History

About 4.0% of 2Seventy Bio are currently held by insiders. Unlike 2Seventy Bio's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against 2Seventy Bio's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of 2Seventy Bio's insider trades
 
Covid

2Seventy Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as 2Seventy Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading 2Seventy Bio backward and forwards among themselves. 2Seventy Bio's institutional investor refers to the entity that pools money to purchase 2Seventy Bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2024-09-30
1.2 M
State Street Corp2024-09-30
1.1 M
Eversept Partners, Llc2024-09-30
998.1 K
Cowen And Company, Llc2024-09-30
800 K
Dafna Capital Management Llc2024-09-30
630 K
Bank Of America Corp2024-06-30
606.8 K
Healthcare Of Ontario Pension Plan Trust Fund2024-09-30
590 K
Venator Management Llc2024-09-30
525 K
Jpmorgan Chase & Co2024-09-30
514.8 K
Kynam Capital Management, Lp2024-09-30
M
Goldman Sachs Group Inc2024-09-30
4.2 M
Note, although 2Seventy Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

2Seventy Bio Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific 2Seventy Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on 2Seventy Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases 2Seventy Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Maus Marcela V. over two weeks ago
Disposition of 00 shares by Maus Marcela V. of 2Seventy Bio at 3.3801 subject to Rule 16b-3
 
Jessica Snow over three months ago
Disposition of 7816 shares by Jessica Snow of 2Seventy Bio at 4.3194 subject to Rule 16b-3
 
Eatwell Victoria over three months ago
Disposition of tradable shares by Eatwell Victoria of 2Seventy Bio at 4.0178 subject to Rule 16b-3
 
Eatwell Victoria over three months ago
Acquisition by Eatwell Victoria of 245864 shares of 2Seventy Bio subject to Rule 16b-3
 
Casdin Capital, Llc over three months ago
Acquisition by Casdin Capital, Llc of 12050 shares of 2Seventy Bio at 3.93 subject to Rule 16b-3
 
Kynam Global Healthcare Master Fund, Lp over three months ago
Acquisition by Kynam Global Healthcare Master Fund, Lp of 86414 shares of 2Seventy Bio at 5.96 subject to Rule 16b-3
 
Jessica Snow over six months ago
Disposition of 649 shares by Jessica Snow of 2Seventy Bio at 4.1823 subject to Rule 16b-3
 
Eatwell Victoria over six months ago
Acquisition by Eatwell Victoria of 85000 shares of 2Seventy Bio at 5.79 subject to Rule 16b-3
 
Gregory Philip D over six months ago
Acquisition by Gregory Philip D of 25000 shares of 2Seventy Bio subject to Rule 16b-3
 
Casdin Capital, Llc over six months ago
Acquisition by Casdin Capital, Llc of 330000 shares of 2Seventy Bio at 5.0727 subject to Rule 16b-3
 
Casdin Capital, Llc over six months ago
Acquisition by Casdin Capital, Llc of 147377 shares of 2Seventy Bio at 5.1166 subject to Rule 16b-3
 
Nick Leschly over six months ago
Sale by Nick Leschly of 72312 shares of 2Seventy Bio

2Seventy Bio Outstanding Bonds

2Seventy Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. 2Seventy Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most 2Seventy bonds can be classified according to their maturity, which is the date when 2Seventy Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

2Seventy Bio Corporate Filings

F4
20th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
12th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
6th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
10Q
8th of August 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for 2Seventy Stock Analysis

When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.